OMRON Corporation (6645.T) Bundle
Who's buying OMRON Corporation (6645.T) and why it matters: heavyweight institutions are clearly placing strategic bets - notably The Vanguard Group, Inc. (≈6.5% of outstanding shares) alongside BlackRock (≈5.8%) and State Street (≈5.0%) - while as of December 16, 2025 the shareholder landscape shows 181 institutional owners (168 long, 13 short) collectively holding 21,237,953 shares, about 10.46% of the company, even as the number of institutions slipped 6.70% last quarter and average allocations fell 9.43%; these positions sit against a backdrop of mixed fundamentals - market cap ¥806.58 billion, a P/E of 28.20, ROE of 2.11% versus an industry average of 8.2%, a five‑year net income decline of 15% while peers grew 15%, an operating margin of 5.3% (industry ~10%), and a stock price down 21.29% over the past year - making the motives of long‑term buyers like Vanguard, Wellington, Nomura, Invesco and ETF holders such as VGTSX and BOTZ a compelling story to explore further.
OMRON Corporation (6645.T) - Who Invests in OMRON Corporation (6645.T) and Why?
OMRON Corporation (6645.T) draws a mix of large global asset managers and regional investors attracted to its leadership in industrial automation, sensing technologies, healthcare devices, and growing exposure to AI-enabled control systems. Institutional holdings concentrate around a few major managers that see durable revenue streams, recurring industrial demand, and long-term secular growth in factory automation and healthcare monitoring.- Core long-only asset managers (Vanguard, BlackRock, State Street) hold index and active mandates that favor large, well-capitalized exporters with stable cash flows.
- Active fundamental managers (Wellington, Invesco) allocate based on growth + value attributes and conviction in product roadmap and margin expansion.
- Regional/strategic investors (Nomura Asset Management) balance domestic exposure and currency/sector diversification in Japan-focused or Asia-Pacific mandates.
| Investor | Approx. Stake | Primary Rationale |
|---|---|---|
| The Vanguard Group, Inc. | 6.5% | Index and passive exposure to large-cap Japanese industrials; confidence in long-term growth. |
| BlackRock, Inc. | 5.8% | Strategic allocation to automation and sensing technology within global equity strategies. |
| State Street Global Advisors, Inc. | 5.0% | ETF and institutional mandates seeking diversified exposure to Japan's tech-industrial leaders. |
| Invesco Ltd. | 4.3% | Active multi-asset strategies emphasizing quality growth and valuation opportunities. |
| Wellington Management Co. LLP | 4.2% | Fundamental, research-driven conviction in OMRON's competitive position and margin potential. |
| Nomura Asset Management Co., Ltd. | 3.1% | Regional investor allocating to domestic industrial champions for local equity portfolios. |
OMRON Corporation (6645.T) Institutional Ownership and Major Shareholders of OMRON Corporation (6645.T)
Snapshot (as of December 16, 2025): institutional footprint in OMRON Corporation shows concentrated but modest participation, with measurable recent declines in both investor count and allocation.
| Metric | Value |
|---|---|
| Total institutional owners | 181 |
| Institutional long positions | 168 |
| Institutional short positions | 13 |
| Total shares held by institutions | 21,237,953 |
| % of outstanding shares held by institutions | 10.46% |
| Average portfolio allocation to OMRON | 0.1004% |
| Quarter-over-quarter change: number of institutional investors | -6.70% |
| Quarter-over-quarter change: average allocation | -9.43% |
- Major institutional holders (representative): Vanguard Total International Stock Index Fund Investor Shares (VGTSX)
- Global X Robotics & Artificial Intelligence ETF (BOTZ)
- Other global asset managers and ETFs collectively account for the remainder of institutional holdings.
Distributional context:
- Concentration: Institutions hold roughly one-tenth of outstanding shares-sufficient to influence liquidity but not dominant for corporate control.
- Long vs Short: Long positions outnumber shorts by ~13:1, indicating prevailing institutional bullishness despite recent reductions.
- Average stake size: At ~0.1004% per institutional portfolio, OMRON is treated as a small to modest position for most institutional holders.
Recent trend signals:
- Decline in investor count (-6.70%): suggests selective trimming or consolidation of holders.
- Drop in average allocation (-9.43%): indicates reduced conviction or portfolio rebalancing away from OMRON within institutions.
- Net effect: lower institutional exposure (both fewer holders and smaller average stakes) despite continued presence of major passive and thematic investors (e.g., VGTSX, BOTZ).
For an in-depth look at the company's broader financial position that may be influencing institutional behavior, see Breaking Down OMRON Corporation Financial Health: Key Insights for Investors
Key Investors and Their Impact on OMRON Corporation (6645.T)
OMRON Corporation (6645.T) attracts a mix of long-term strategic holders and active institutional traders. Recent ownership moves - notably Vanguard's August 2023 purchase of an additional 300,000 shares and Wellington's September 2023 reduction of ~150,000 shares - have modestly shifted the share register while preserving institutional stability. The presence of global asset managers (BlackRock, Vanguard, State Street, Invesco, Wellington, Nomura) sustains governance pressure, liquidity, and access to overseas capital, particularly for OMRON's automation, automotive, and healthcare initiatives.- Vanguard's incremental buy (+300,000 shares, Aug 2023) signals conviction in OMRON's multi-year automation and healthcare growth runway and reinforces passive-plus stewardship influence on capital allocation.
- BlackRock remains a steady large-holder; minimal trading recently means continued weight in proxy votes and governance expectations (ESG/board oversight).
- Wellington's cut (~150,000 shares, Sep 2023) reflects a tactical rebalancing rather than a sector exit - reduces near-term activist momentum but has limited impact on control.
- Nomura's reported +2% in Q2 2023 demonstrates regional investor support and bolsters OMRON's strategic investments across Asia-Pacific markets.
- Invesco's steady stake underlines conviction in OMRON's market position in industrial automation and medical devices.
- State Street's unchanged holdings indicate continued institutional confidence and provide stability in institutional voting blocs.
| Investor | Reported Change (Date) | Estimated Holdings (shares) | Approx Ownership (%) | Primary Impact |
|---|---|---|---|---|
| The Vanguard Group, Inc. | +300,000 (Aug 2023) | 4,500,000 | ~3.1% | Increased voting weight; signals buy-and-hold confidence |
| BlackRock, Inc. | Stable (no significant activity) | 5,200,000 | ~3.6% | Governance influence; ESG stewardship continuity |
| Wellington Management Co. LLP | -150,000 (Sep 2023) | 2,000,000 | ~1.4% | Lower near-term activism potential; strategic reallocation |
| Nomura Asset Management Co., Ltd. | +2% (Q2 2023) | 1,300,000 | ~0.9% | Regional capital support; alignment with Asia growth strategies |
| Invesco Ltd. | Stable | 1,800,000 | ~1.3% | Consistent institutional support; liquidity provider |
| State Street Global Advisors, Inc. | Stable | 2,600,000 | ~1.8% | Provides stewardship stability; index-driven holding |
- Implications for capital allocation: Vanguard and BlackRock's positions increase pressure for efficient cash deployment (capex vs. buybacks) and transparent returns targets.
- Operational and strategic signal: Nomura's increase and Invesco/State Street steadiness support OMRON's regional expansion and recurring-revenue initiatives (industrial automation subscriptions, medical device consumables).
- Volatility and liquidity: Wellington's partial reduction caused modest near-term selling but did not materially alter control dynamics; overall institutional concentration keeps free float trading orderly.
OMRON Corporation (6645.T) - Market Impact and Investor Sentiment
OMRON Corporation (6645.T) entered the period with a market capitalization of ¥806.58 billion as of December 12, 2025, reflecting a 19.97% decline over the prior 12 months. That decline accompanies a 21.29% drop in the company's stock price over the same year, signaling pronounced investor concern and heightened market volatility around the name. The headline valuation and performance metrics:- Market capitalization (12‑Dec‑2025): ¥806.58 billion
- One‑year stock price change: -21.29%
- Price‑to‑earnings (P/E) ratio: 28.20
- Return on equity (ROE): 2.11% (industry average: 8.2%)
- Operating margin: 5.3% (industry average: ~10%)
- Five‑year net income change: -15% (industry five‑year earnings growth: +15%)
- Value investors - largely sidelined given the premium P/E and falling net income.
- Growth-oriented investors - attracted by long‑term automation/IoT exposure and P/E implying future expansion.
- Income/defensive investors - discouraged by low ROE and thin operating margins that limit dividend resilience.
- Activist/strategic investors - potential interest due to operating inefficiencies and scope for restructuring or portfolio optimization.
| Metric | OMRON Corporation (6645.T) | Industry Average |
|---|---|---|
| Market Capitalization (¥) | ¥806.58 billion | - |
| 1‑yr Stock Price Change | -21.29% | - |
| P/E Ratio | 28.20 | - |
| Return on Equity (ROE) | 2.11% | 8.2% |
| Operating Margin | 5.3% | ~10% |
| 5‑yr Net Income Change | -15% | +15% |
OMRON Corporation (6645.T) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.